Search

everythinglearnresearchcommunity

for

Search:↓

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Sebocytes play a key role in controlling androgen levels in human skin.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

New compounds show promise as nonsteroidal treatments for hair loss.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Some herbs show promise as antiandrogenic agents.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Minoxidil with caffeine works better for hair loss than minoxidil alone.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Compounds from the plant Mammea siamensis may help treat hair loss.

Androgens may influence bladder cancer progression by affecting cellular behavior.